EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Melittin Reprograms Tumor‐Associated Macrophages Through CD18 ‐Mediated Immunomodulation

Ik-Hwan Han iD, Hyunju Lee iD, Eunbin Ko iD, Ilseob Choi iD, Soyoung Kim iD, Deok-Sang Hwang, Hyunsu Bae iD

Phytotherapy Research · 2026-11 · 40 (11) · 6201-6215

DOI: 10.1002/ptr.70431 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-08-20. Written by Ik-Hwan Han and 6 co-authors. Institution: Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea. Major MEDLINE topics: Melitten, Tumor-Associated Macrophages, Immunomodulation. 32 references. The full text is freely available (open access, CC BY 4.0). Funded by: Ministry of Science and ICT, South Korea, Korea Institute for Advancement of Technology, Technology Commercialization Promotion Program.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Tumor‐associated macrophages (TAMs), particularly the M2‐like subtype, contribute to an immunosuppressive tumor microenvironment and promote tumor progression. Melittin, a natural bioactive peptide derived from bee venom, has been reported to exert anticancer and immunomodulatory effects; however, the cellular targets and molecular mechanisms underlying its selective action on TAMs remain incompletely defined. This study aimed to investigate the immunomodulatory effects of melittin on TAM subsets and to identify the molecular determinant responsible for its selectivity toward M2‐like macrophages. Macrophage subsets were analyzed following melittin treatment using flow cytometry, gene expression analysis, and immunofluorescence. Binding interactions were assessed by biochemical and biophysical approaches. Tumor growth and immune cell composition were examined in wild‐type and CD18‐deficient mice. Melittin treatment selectively reduced M2‐like TAM populations while increasing infiltration of CD8 + cytotoxic T cells in tumor tissues. Mechanistic analyses revealed that melittin preferentially binds to the integrin subunit CD18 (ITGB2), which is enriched in M2‐polarized macrophages, leading to disruption of M2‐associated phenotypes in vitro. Notably, genetic deletion of CD18 abolished the M2‐suppressive and antitumor effects of melittin in vivo. These findings demonstrate that CD18 is functionally required for the immunomodulatory and antitumor activities of native full‐length melittin. This study provides mechanistic insight into the selective action of a natural bioactive peptide and supports its potential as a lead compound for natural product‐based immunomodulatory strategies.

Subjects

MeSH terms (MEDLINE)

MelittenTumor-Associated MacrophagesImmunomodulationAnimalsMiceMice, Inbred C57BLTumor MicroenvironmentMacrophagesCell Line, Tumor

Author keywords

CD18immunomodulationlung carcinomamelittintumor‐associated macrophages

Substances

Melitten

Authors and institutions

  • Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
  • Department of Clinical Korean Medicine, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
  • Twinpig Biolab Inc. R&D Center, Seoul, Republic of Korea.

ORCID profiles: Ik-Hwan Han, Hyunju Lee, Eunbin Ko, Ilseob Choi, Soyoung Kim, Hyunsu Bae

Funding

  • Ministry of Science and ICT, South Korea
  • Korea Institute for Advancement of Technology
  • Technology Commercialization Promotion Program

Cite

APA

Han, I. H., Lee, H., Ko, E., Choi, I., Kim, S., Hwang, D. S., & Bae, H. (2026). Melittin Reprograms Tumor‐Associated Macrophages Through CD18 ‐Mediated Immunomodulation. Phytotherapy Research, 40(11), 6201-6215. https://doi.org/10.1002/ptr.70431

Vancouver

Han IH, Lee H, Ko E, Choi I, Kim S, Hwang DS, et al. Melittin Reprograms Tumor‐Associated Macrophages Through CD18 ‐Mediated Immunomodulation. Phytotherapy Research. 2026;40(11):6201-6215. doi:10.1002/ptr.70431

BibTeX
@article{Han2026,
  author = {Han, Ik-Hwan and Lee, Hyunju and Ko, Eunbin and Choi, Ilseob and Kim, Soyoung and Hwang, Deok-Sang and Bae, Hyunsu},
  title = {Melittin Reprograms Tumor‐Associated Macrophages Through CD18 ‐Mediated Immunomodulation},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {11},
  pages = {6201--6215},
  doi = {10.1002/ptr.70431}
}
Start for free →